Cytosorbents Corporation
CTSO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21 | -$29 | -$33 | -$25 |
| Dep. & Amort. | $2 | $2 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $4 | $4 | $6 |
| Change in WC | -$4 | $2 | -$4 | $1 |
| Other Non-Cash | $5 | -$1 | $3 | $3 |
| Operating Cash Flow | -$14 | -$22 | -$28 | -$14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$6 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$1 | -$6 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10 | $0 | $5 | $0 |
| Stock Issued | $0 | $14 | -$0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $0 | $0 | $0 |
| Financing Cash Flow | $9 | $14 | $5 | $1 |
| Forex Effect | -$0 | -$0 | -$0 | -$0 |
| Net Chg. in Cash | -$6 | -$8 | -$30 | -$18 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16 | $24 | $54 | $71 |
| End Cash | $10 | $16 | $24 | $54 |
| Free Cash Flow | -$15 | -$23 | -$35 | -$18 |